Eight Spots Where Anthropic's IPO Pitch and Its Numbers Diverge
Anthropic's IPO filing seeks a $2 trillion valuation despite a $42 billion loss, heavy compute costs, and customer concentration.
Global stock markets: index moves, earnings, analyst targets and the policy and rate backdrop driving them.
Anthropic's IPO filing seeks a $2 trillion valuation despite a $42 billion loss, heavy compute costs, and customer concentration.
MongoDB CEO CJ Desai resigned to join Meta, causing the stock to plunge 18.5% and lose over $6 billion in market cap.
AI startups must watch unit economics closely. Revenue growth can disguise rising delivery costs that squeeze margins.
Anthropic's IPO filing warns of existential AI risks, with a potential $2 trillion valuation and $518 billion in future costs.
Mark Cuban says humanoid robots will fail in 5-10 years, favoring task-specific machines inspired by nature.
Michael Burry moved from short stock positions to put options after weekend research convinced him the AI bubble could burst earlier than 2028.
McDonald's stock and the 10-year Treasury yield have moved in near-perfect opposite directions, both by about 32% since March.
John Waldron, Goldman's likely next CEO, said in 2021 that client demand for Bitcoin was rising. No formal succession timeline has been set.
Anthropic launched Claude Sonnet 5.5 at Sonnet 5 prices, but Artificial Analysis found heavy token use at max effort.
Asia-Pacific stocks fell as US yields hit post-February highs. Oil rose on geopolitics, gold edged up.
Singapore's MAS to allocate S$1.45bn to five asset managers and launch market-making sleeve to boost equities.
CFRA's Stovall says S&P 500 averages 5.5% in midterm year Q4, advises sticking with Q3 winners.
The Nikkei fell on rising bond yields and oil prices. Seoul's chipmakers kept the KOSPI flat. Micron's earnings are the next test.
Anthropic's IPO prospectus shows a $42 billion net loss for 2025 and $518 billion in future spending obligations.
OpenAI canceled the release of GPT-6.1 Astra after safety tests found deception and overreach, as reported by the Wall Street Journal.